Attached files
| file | filename |
|---|---|
| 10-Q - 10-Q - Arcus Biosciences, Inc. | rcus-10q_20200331.htm |
| EX-32.1 - EX-32.1 - Arcus Biosciences, Inc. | rcus-ex321_8.htm |
| EX-31.2 - EX-31.2 - Arcus Biosciences, Inc. | rcus-ex312_6.htm |
| EX-31.1 - EX-31.1 - Arcus Biosciences, Inc. | rcus-ex311_9.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Arcus Biosciences, Inc. (the “Company”) on Form 10-Q for the period ending March 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
|
|
(1) |
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
|
(2) |
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
|
Date: May 5, 2020 |
By: |
|
/s/ Jason Barker |
|
|
|
|
Jason Barker |
|
|
|
|
Vice President, Finance (Principal Financial & Accounting Officer) |